Duo Security’s hosted two-factor authentication service brings strong, scalable security to organizations of any size. Duo’s unique, high-availability architecture provides centralized management, self-service enrollment, and interactive secondary login through an intuitive web interface, eliminating the high costs, complexity, and confusion associated with traditional two-factor systems. Every day, over 500 organizations in 40+ countries around the world rely on Duo for their security. This investment is through ResonantVC.
GeoDigital International, strives to meet the unique needs of every client. They provide laser based solutions for field data acquisition, asset mapping and visual infrared inspection – providing turnkey solutions for the Electric Utility, Highway & Road, Railway, Pipeline, Telecommunications, Fire Mapping and Utility Vegetation Management industries.
Green & Grow Inc. (GGI) is dedicated to developing and commercializing naturally derived compounds with new methods of action.
Trials to date show that GGI has successfully refined its Agriplier™ Technology for integration into multiple seed treatment processes and for liquid application as well as a soil amendment. Agriplier products are easy to apply, water soluble, and have a long shelf life. In addition, these fertilizers are not subject to the potential performance uncertainty inherent in the use of live micro-organisms and can be applied simultaneously with standard fertilizers, nutrients or crop protection products. GGI offers products that are USDA Certified as 100% Biobased and suited for organic farming.
Neurodyn Inc. is a Canadian biotechnology company utilizing a portfolio approach to develop bioactives for the early treatment of neurological diseases. Neurodyn’s drug candidate suite includes NeuroPro, a neuroprotection product for early stage Parkinson’s disease, ND602 a novel therapeutic which demonstrates in vivo pre-clinical efficacy in ALS, PD, Alzheimer’s and Spinal Muscular Atrophy, and NQ1123, a topical nerve pain treatment which lacks the numbing or burning effects caused by other products currently on the market. In addition, Neurodyn houses a proprietary suite of animal models which are highly predictive, environmentally-based, and can replicate multiple aspects of human neurological disease states.
With the acquisition of Galantos Pharma, Neurodyn’s portfolio now includes Memogain, a new pro-drug of the FDA-approved Galantamine. Memogain® has the potential to achieve a much higher concentration in the brain while avoiding the systemic adverse effects of existing Alzheimer’s drugs. After the close of successful phase 1A & B human clinical trials, Memogain is slated to begin phase 2 trials in 2015.
OsComp Systems has developed a breakthrough compression technology that decreases the energy required to compress and transport natural gas. This new technology allows production to continue on wells that would not otherwise be feasible to run and can significantly increase the production of other wells. OsComp has completed an initial design for a 100kW compressor prototype that is due to begin full systems testing in early October.
PeraHealth is enabling comprehensive analysis of patient health. The company’s Rothman Index is a single score that is calculated for a patient using 26 common observations and results that are already available from the hospital’s EHR system. The Rothman Index and display allows medical personnel the ability to simultaneously see multiple patient graphs to attain a high level understanding of an entire unit. The Index graphs automatically update hourly for each patient and produce a graph of the patient’s score for the last several days. This creates an easily understood picture of the patient’s condition so physicians and nurses can spend less time analyzing data and more time treating patients.
Resonant Venture Partners is an emerging venture capital firm based in Ann Arbor, Michigan. Founded in 2010, Resonant makes seed stage investments in companies developing cloud infrastructure, software and services. Entrepreneurs in their own right, the managing directors partner with portfolio companies through challenging product, market and operational issues at the earliest phases. At the same time, Resonant maintains a top tier back office, a disciplined approach to venture investing and a high level of service to their limited partners.